IGF1R and breast neoplasm: Recent DNA affinity chromatography-based proteomic analyses using nuclear extracts of breast tumor cells along with biotin-labeled IGF1R promoter fragments, followed by mass spectroscopy, led to the identification of a large set of IGF1R promoter-binding transcription factors (41).